NORDIC BIOSCIENCE A/S: Financial statements 2022
CVR: 30799968
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NORDIC BIOSCIENCE A/S (CVR 30799968) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 313,570,105 and a net result of DKK 113,233,569 compared with DKK 104,795,685 the year before. That is an increase of 15.7% compared with the year before. The profit margin was 36.1%. Equity in the 2022 report amounted to DKK 71,666,978. The solvency ratio was 26.4%. The company had 167 employees in the financial year.
- Revenue
- DKK 313,570,105
- Gross Profit
- DKK 263,245,680
- Profit/Loss
- DKK 113,233,569
- Equity
- DKK 71,666,978
- Total Assets
- DKK 271,866,576
- Employees
- 167
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 313.6 mio. | 263.2 mio. | 113.2 mio. | 71.7 mio. | 167 |
| 2021 | 271 mio. | 239.1 mio. | 104.8 mio. | 117.7 mio. | 150 |
| 2020 | - | 255 mio. | 93.4 mio. | 113.4 mio. | 136 |
| 2019 | - | 216.2 mio. | 74.3 mio. | 120.1 mio. | 133 |
| 2018 | - | 231.6 mio. | 76.3 mio. | 104.8 mio. | 103 |
Official annual report
Keep an eye on NORDIC BIOSCIENCE A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NORDIC BIOSCIENCE A/S has published its annual report for 2021. Revenue came to DKK 271,013,538, and the net result was DKK 104,795,685.
About NORDIC BIOSCIENCE A/S
NORDIC BIOSCIENCE A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Morten Asser Karsdal. The board consists of Bente Juel Christiansen, Claus Henrik Christiansen and Thomas Nielsen. The company is owned by NORDIC BIOSCIENCE HOLDING A/S. The company has 206 employees (2026). In 2025, the company reported revenue of DKK 379,345,000 and a net result of DKK 96,537,000 compared with DKK 78,388,000 the year before. Equity in the 2025 report amounted to DKK 131,205,000.